Found 1646 bookmarks
Newest
21 'Pathogenic Bacteria' Detected on Kids' Face Masks GreenMedInfo
21 'Pathogenic Bacteria' Detected on Kids' Face Masks GreenMedInfo
A group of concerned parents had children's face masks independently tested after they'd been worn for a typical school day. The startling results reveal a range of bacteria associated with pathogenicity, including 11 strains scientists described as "quite dangerous"
·greenmedinfo.com·
21 'Pathogenic Bacteria' Detected on Kids' Face Masks GreenMedInfo
Ivermectin for Prevention and Treatment of COVID-19 Infectio... American Journal of Therapeutics
Ivermectin for Prevention and Treatment of COVID-19 Infectio... American Journal of Therapeutics
mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection. Data sources: We searched bibliographic databases up to April 25, 2021. Two review authors sifted for studies, extracted data, and assessed risk of bias. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses for mortality. Twenty-four randomized controlled trials involving 3406 participants met review inclusion. Therapeutic Advances: Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n = 2438; I2 = 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,” whereas effect estimates for “improvement” and “deterioration” clearly favored ivermectin use. Severe adverse events were rare among treatment trials and evidence of no difference was assessed as low certainty. Evidence on other secondary outcomes was very low certainty. Conclusions: Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally. Address for correspondence: Population Health Sciences Institute, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle Upon Tyne NE2 4AX, United Kingdom. E-mail: andy.bryant@ncl.ac.uk The preprint of this review received no funding. This updated version was funded by the crowdfunding initiative https://www.gofundme.com/f/help-us-get-lifesaving-drug-approved-for-covid19 The authors have no conflicts of interest to declare. T. A. Lawrie and A. Bryant cowrote the review; they also sifted the search and classified studies for inclusion and entered and checked the data in RevMan and performed analyses. Data extraction was divided among T. A. Lawrie, A. Bryant, and T. Dowswell. T. Dowswell and A. Bryant graded the evidence. E. J. Fordham prepared the text on ivermectin mechanisms, use in pregnancy, and among the elderly. S. R. Hill prepared the brief economic commentary. Clinicians S. Mitchell and T. C. Tham contributed to the interpretation of the evidence in the discussion and conclusions. All authors reviewed and approved the final version of the manuscript. This article discusses off-label use of the FDA-approved medication ivermectin against COVID-19. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved....
·journals.lww.com·
Ivermectin for Prevention and Treatment of COVID-19 Infectio... American Journal of Therapeutics
! Pfizer data REVEAL - Where do the lipid nanoparticles collect (Robert Malone, Steve Kirsch, Bret W)
! Pfizer data REVEAL - Where do the lipid nanoparticles collect (Robert Malone, Steve Kirsch, Bret W)
Spike protein collects in ovaries and bone marrow according to Pfizer data from Japan. Clip from DarkHorse podcast. Full livestream CENSORED on YouTube Join us on Odysee https://odysee.com/@BretWeinstein:f https://odysee.com/@DarkHorsePodcastClips:b Full livestream here: Odysee for backup: https://odysee.com/@BretWeinstein:f/how-to-save-the-world,-in-three-easy:0 Dr. Robert Malone is the inventor of mRNA Vaccine technology. Mr. Steve Kirsch is a serial entrepreneur who has been researching adverse reactions to COVID vaccines. Bret talks to Robert and Steve about the pandemic, treatment and the COVID vaccines. Steve's paper on COVID vaccine reactions: https://trialsitenews.com/should-you-get-vaccinated/ Steve's Twitter: https://twitter.com/stkirsch COVID-19 Early Treatment Fund: https://www.treatearly.org/team/steve-kirsch Dr. Malone's website: https://www.rwmalonemd.com/mrna-vaccine-inventor Robert's LinkedIn profile: https://www.linkedin.com/in/rwmalonemd Robert's Twitter: https://twitter.com/RWMaloneMD Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. https://www.patreon.com/bretweinstein https://twitter.com/BretWeinstein Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org Theme Music: Thank you to Martin Molin of Wintergatan for providing us the rights to use their excellent music.
·odysee.com·
! Pfizer data REVEAL - Where do the lipid nanoparticles collect (Robert Malone, Steve Kirsch, Bret W)
! Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) - YouTube
! Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) - YouTube
Spike protein is very dangerous, it's cytotoxic. Clip from DarkHorse podcast. Full livestream here: https://youtu.be/-_NNTVJzqtY Bitchute for backup: https://www.bitchute.com/video/TH2HAmTp40xq/ Dr. Robert Malone is the inventor of mRNA Vaccine technology. Mr. Steve Kirsch is a serial entrepreneur who has been researching adverse reactions to COVID vaccines. Bret talks to Robert and Steve about the pandemic, treatment and the COVID vaccines. Steve's paper on COVID vaccine reactions: https://trialsitenews.com/should-you-get-vaccinated/ Steve's Twitter: https://twitter.com/stkirsch COVID-19 Early Treatment Fund: https://www.treatearly.org/team/steve-kirsch Dr. Malone's website: https://www.rwmalonemd.com/mrna-vaccine-inventor Robert's LinkedIn profile: https://www.linkedin.com/in/rwmalonemd Robert's Twitter: https://twitter.com/RWMaloneMD Find Bret Weinstein on Twitter: @BretWeinstein, and on Patreon. https://www.patreon.com/bretweinstein https://twitter.com/BretWeinstein Please subscribe to this channel for more long form content like this, and subscribe to the clips channel @DarkHorse Podcast Clips for short clips of all our podcasts. DarkHorse merchandise now available at: store.darkhorsepodcast.org Theme Music: Thank you to Martin Molin of Wintergatan for providing us the rights to use their excellent music.
·youtube.com·
! Spike protein is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) - YouTube
Introduction to COVID Treatments
Introduction to COVID Treatments
Doctors worldwide were actively discouraged from helping and even prevented from saving their patients. Esteemed doctors and medical facilities have developed effective treatment protocols for COVID-19, including Harvard, Johns Hopkins, and Emory. Yet, all have been suppressed and censored in an apparent effort to cause as much suffering and death as possible. In the world... View Article
·drsircus.com·
Introduction to COVID Treatments
! Microvascular dysfunction in COVID-19 the MYSTIC study - PubMed
! Microvascular dysfunction in COVID-19 the MYSTIC study - PubMed
Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19.
·pubmed.ncbi.nlm.nih.gov·
! Microvascular dysfunction in COVID-19 the MYSTIC study - PubMed
Episode 219 IN HARM’S WAY - The Highwire
Episode 219 IN HARM’S WAY - The Highwire
#ICANFauciEmails Hit Mainstream; TX & FL Rock Cruise Lines; Dr. Mike Yeadon Exposes Possible Covid Fraud; Utah Family Devastated By Covid Vaccine Guests: Cherie Romney & Dr. Mike Yeadon #FauciEmails #FauciLeaks #Fauci #TuckerCarlson #Texas #Covid19 #EverestRomney #MikeYeadon ORIGINAL AIR-DATE: June 10, 2021
·thehighwire.com·
Episode 219 IN HARM’S WAY - The Highwire
Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin - PubMed
Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin - PubMed
RNA virus infections can lead to the onset of severe diseases such as fever with haemorrhage, multiorgan failure, and mortality. The emergence and reemergence of RNA viruses continue to pose a significant public health threat worldwide with particular attention to the increasing incidence of flavivi …
·pubmed.ncbi.nlm.nih.gov·
Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin - PubMed
Webinar Dr Darrell DeMello about Early Treatment - YouTube
Webinar Dr Darrell DeMello about Early Treatment - YouTube
We are pleased to present highlights of our webinar with Dr Darrell DeMello, who is one of these innovative medical doctors who has treated numerous COVID-19 patients and continuously improved his protocols. Dr Darrell DeMello has considerable experience with COVID-19. So far, he has treated some 6,000 COVID-19 patients and provided prophylaxis to many more family members. Note that only highlights of the webinar are presented here. Note also that the Internet connection with India, where he is located, was poor, hence the poor quality of the video. We also expect to post shortly more details about his protocols at http://covexit.com
·youtube.com·
Webinar Dr Darrell DeMello about Early Treatment - YouTube
1 NORS for COVID-19 - Sanotize
1 NORS for COVID-19 - Sanotize
[vc_row css=”.vc_custom_1585688571105{padding-top: 50px !important;padding-bottom: 15px !important;}”][vc_column width=”1/2″][vc_column_text] NORS as an upper airway “disinfectant” SaNOtize has demonstrated the effectiveness of its NORS formulation in eradicating different types of viruses, including influenza and H1N1, and is working diligently to determine its efficacy for preventing and treating COVID-19 infections. At present, SaNOtize: Completed a randomized, double-blind, placebo-controlled trial that evaluated […]
·sanotize.com·
1 NORS for COVID-19 - Sanotize
1 UK Clinical Trial for A Nasal Spray for COVID - Amazing Results - YouTube
1 UK Clinical Trial for A Nasal Spray for COVID - Amazing Results - YouTube
UK Clinical Trial for A Nasal Spray for COVID - Amazing Results Today we will discuss the UK clinical trial of the nitric oxide based nasal spray. Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19 https://www.businesswire.com/news/home/20210315005197/en/UK-Clinical-Trial-Confirms-SaNOtize%E2%80%99s-Breakthrough-Treatment-for-COVID-19 DrBeen’s earlier video about this product https://youtu.be/u-e_XYYHApA #drbeen #koolbeens #COVID
·youtube.com·
1 UK Clinical Trial for A Nasal Spray for COVID - Amazing Results - YouTube
9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
Acute Respiratory Distress Syndrome (ARDS) causes up to 40% mortality in humans and is difficult to treat. ARDS is also one of the major triggers of mortality associated with coronavirus-induced disease (COVID-19). We used a mouse model of ARDS induced by Staphylococcal enterotoxin B (SEB), which tr …
·pubmed.ncbi.nlm.nih.gov·
9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
An Update on Current Therapeutic Drugs Treating COVID-19 - PubMed
An Update on Current Therapeutic Drugs Treating COVID-19 - PubMed
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented challenges to the healthcare systems in almost every country around the world. Currently, there are no proven effective vaccines or therapeut …
·pubmed.ncbi.nlm.nih.gov·
An Update on Current Therapeutic Drugs Treating COVID-19 - PubMed
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches - PubMed
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches - PubMed
Effective treatment choices to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are limited because of the absence of effective target-based therapeutics. The main object of the current research was to estimate the antiviral activity of cannabinoids (CBDs) against the human coronavir …
·pubmed.ncbi.nlm.nih.gov·
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches - PubMed